Please Wait

Applying Filters...

Falecalcitriol
EU WC
Table View

AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Falecalcitriol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 12 USDMF, 7 CEP/COS, 3 JDMF, 1 EU WC, 5 KDMF, 7 NDC API, 24 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 35 FDA Orange Book, 40 Europe, 8 Canada, 16 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 8 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 Finar, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 4 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 17 Taste Masking, 16 Parenteral, 15 Chewable & Orodispersible Aids, 14 Direct Compression, 12 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 10 Coating Systems & Additives, 9 Solubilizers, 9 Topical, 8 Thickeners and Stabilizers, 8 Empty Capsules, 8 Co-Processed Excipients, 4 Granulation, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 2 Controlled & Modified Release, 2 Emulsifying Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

9 APIs, 12 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
10/07/2020	Avik Pharmaceutical Limited	India	M/s. Avik Pharmaceutical Limited	WC-0169	Calcitriol(BP/EP)	2019-06-27	2022-07-02	A-1/7, 1st Phase GIDC, Vapi-396 195, Valsad, Gujarat, India

Contact us
to update this info

Falecalcitriol

Falecalcitriol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

12 USDMF

7 CEP/COS

3 JDMF

1 EU WC

5 KDMF

7 NDC API

24 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers

35 FDA Orange Book

40 Europe

8 Canada

16 Australia

1 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

17 SPI Pharma

8 DKSH

2 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

1 Finar

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

4 Kerry

3 Lonza Capsugel

2 Microlex e.U

3 Pluviaendo

1 Qualicaps

19 Roquette

4 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

17 Taste Masking

16 Parenteral

15 Chewable & Orodispersible Aids

14 Direct Compression

12 Film Formers & Plasticizers

10 Disintegrants & Superdisintegrants

10 Coating Systems & Additives

9 Solubilizers

9 Topical

8 Thickeners and Stabilizers

8 Empty Capsules

8 Co-Processed Excipients

4 Granulation

3 Coloring Agents

2 Surfactant & Foaming Agents

2 Controlled & Modified Release

2 Emulsifying Agents

1 Soft Gelatin

DIGITAL CONTENT

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons